LBX Pharmacy Chain Joint Stock announcement, the closing price of the company's stock has experienced abnormal fluctuations for three consecutive trading days, with a cumulative deviation exceeding 20%. After self-examination by the company and written inquiries to the controlling shareholder and one of the actual controllers, it has been confirmed that there is no significant information that should be disclosed but has not been disclosed. The company's main business and operating conditions have not undergone significant changes, and there are no circumstances of significant changes expected to occur in the internal and external operating environment. The company has not found any media reports or market rumors that need clarification or response, nor has it discovered any other significant events that have had a significant impact on the company's stock price or are related to market hot topics. During the period of abnormal stock fluctuations, the directors, supervisors, senior management personnel, controlling shareholders, and actual controllers of the company did not buy or sell the company's stock.